Comprehensive Financial Management’s PhenomeX Inc. Common Stock CELL Stock Holding History

Comprehensive Financial Management’s Portfolio CELL Stock Details CELL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-517,793	Closed	-$517K	–	47
2023 Q3	$517K	Hold	517,793	–	–	0.02%	36
2023 Q2	$254K	Hold	517,793	–	–	0.01%	40
2023 Q1	$601K	Hold	517,793	–	–	0.02%	38
2022 Q4	$1.39M	Hold	517,793	–	–	0.04%	28
2022 Q3	$1.48M	Hold	517,793	–	–	0.04%	31
2022 Q2	$2.57M	Hold	517,793	–	–	0.07%	23
2022 Q1	$3.68M	Hold	517,793	–	–	0.07%	25
2021 Q4	$9.41M	Hold	517,793	–	–	0.12%	18
2021 Q3	$10.1M	Hold	517,793	–	–	0.1%	17
2021 Q2	$23.2M	Hold	517,793	–	–	0.19%	14
2021 Q1	$26M	Sell	517,793 -57,000	-10%	-$3.89M	0.26%	12
2020 Q4	$51.4M	Buy	+574,793	New	+$48.3M	0.53%	8

Comprehensive Financial Management's CELL Position: Q4 2023 in Review

Comprehensive Financial Management sold out of PhenomeX Inc. Common Stock (CELL) in Q4 2023, closing a stake of 517,793 shares — an estimated $517K sold.

Comprehensive Financial Management first reported a position in CELL in Q4 2020 and held it in 12 quarters. The position peaked at $51.4M in Q4 2020. 0 funds tracked by Wall St. Rank hold CELL as of Q4 2023.

Comprehensive Financial Management reported no remaining PhenomeX Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Comprehensive Financial Management sold 517,793 PhenomeX Inc. Common Stock shares in Q4 2023, an estimated $517K.
Comprehensive Financial Management first reported a position in PhenomeX Inc. Common Stock in Q4 2020 and held it in 12 quarters.
Comprehensive Financial Management's PhenomeX Inc. Common Stock position peaked at $51.4M in Q4 2020.
0 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q4 2023.

Based on Comprehensive Financial Management's 13F filing for Q4 2023, filed 14 Feb 2024.